Several novel approaches to inhibit interactions between AR and its co-factors by using peptidomimetics have been tested to inhibit the activity of both AR and its co-factors in PCa cell lines and xenograft mice, which show promising results. The gene discussed is AR; the disease is posterior cortical atrophy.